Ginsenoside Rh2 attenuates the progression of non‐small cell lung cancer by sponging miR‐28‐5p/STK4 axis and inactivating Wnt/β‐catenin signaling
Open Access
- 20 April 2023
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 12 (11) , 12653-12667
Abstract
Background: Ginsenoside Rh2 (G‐Rh2) exerts anti‐tumor activity in non‐small cell lung cancer (NSCLC). microRNAs (miRNAs, miRs) play pivotal roles in NSCLC. We aimed to investigate whether G‐Rh2 inhibited NSCLC progression by targeting miRNA.Methods: Cell viability, apoptosis and cycle were determined by Cell Counting Kit‐8, 6‐diamidino‐2‐phenylindole (DAPI) staining and flow cytometry. The potential target miRNAs of G‐Rh2 were screened by real‐time quantitative polymerase chain reaction (RT‐qPCR). The difference in miR‐28‐5p expression between lung adenocarcinoma (LUAD) tissues and normal tissues or lung squamous cell carcinoma (LUSC) tissues and normal tissues was retrieved from TCGA‐LUAD and TCGA‐LUSC, respectively. Kaplan–Meier Plotter was conducted to analyze the survival rate for different serine/threonine‐protein kinase 4 (STK4) expressions with different prognostic risks. immunohistochemistry of STK4 expression in non‐tumor and tumor tissues was analyzed from the HPA database. RT‐qPCR and Western blot were adopted for detecting mRNA and protein expression. TargetScan V7.2, miRanda and PITA were adopted for predicting targets of miR‐28‐5p, overlapped genes were subjected to GO analysis. The interactions of miR‐28‐5p‐Wnt and miR‐28‐5p‐STK4 were detected by TOP/FOP luciferase reporter assay and dual luciferase reporter assay, respectively.Results: Current study observed that G‐Rh2 reduced miR‐28‐5p expression in NSCLC cells dose‐dependently. miR‐28‐5p was upregulated in NSCLC tissues and cells. The target genes of miR‐28‐5p were enriched in negative regulation of Wnt signaling. miR‐28‐5p inhibitor inactivated Wnt signaling, inhibited cell viability and cell cycle, while enhanced cell apoptosis of NSCLC cells by targeting STK4. G‐Rh2 exerted the similar effects with miR‐28‐5p inhibitor by reducing miR‐28‐5p. G‐Rh2 and miR‐28‐5p inhibitor exerted a synergistic effect on inhibiting NSCLC tumor growth.Conclusion: In conclusion, G‐Rh2 attenuates NSCLC development by affecting miR‐28‐5p/STK4 axis and inactivating Wnt signaling. Taken together, we project out a novel therapeutic target for NSCLC.Keywords
Funding Information
- National Natural Science Foundation of China (81672973, 81703758)
This publication has 35 references indexed in Scilit:
- Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivoCancer Gene Therapy, 2013
- The Long and Short of MicroRNACell, 2013
- Maintenance Chemotherapy for Advanced Non–Small-Cell Lung Cancer: New Life for an Old IdeaJournal of Clinical Oncology, 2013
- Ginsenoside Rh2 mediates changes in the microRNA expression profile of human non-small cell lung cancer A549 cellsOncology Reports, 2012
- Updates in Non-Small Cell Lung CancerClinical Journal of Oncology Nursing, 2008
- microRNAs as oncogenes and tumor suppressorsDevelopmental Biology, 2007
- Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cellsCancer Chemotherapy and Pharmacology, 2005
- MicroRNAsCell, 2004
- microRNAsCell, 2001
- Chemistry and Cancer Preventing Activities of Ginseng Saponins and Some Related Triterpenoid CompoundsJournal of Korean Medical Science, 2001